Wells Fargo’s Whitehawk Therapeutics WHWK Stock Holding History
Bought
Maintained
Sold
Other funds holding WHWK
YF
SL
Wells Fargo's WHWK Position: Q3 2026 in Review
Wells Fargo reduced its Whitehawk Therapeutics (WHWK) stake by 69% in Q3 2026, selling an estimated $78.8K and leaving 8,469 shares worth $31.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5729.
Wells Fargo first reported a position in WHWK in Q1 2020 and has held it in 23 quarters since. The position peaked at $124K in Q2 2026. 91 funds tracked by Wall St. Rank hold WHWK as of Q3 2026.
- Wells Fargo held 8,469 shares of Whitehawk Therapeutics worth $31.8K as of Q3 2026.
- Wells Fargo sold 18,705 Whitehawk Therapeutics shares in Q3 2026, an estimated $78.8K.
- Whitehawk Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q3 2026, its #5729 holding.
- Wells Fargo first reported a position in Whitehawk Therapeutics in Q1 2020 and has held it in 23 quarters since.
- Wells Fargo's Whitehawk Therapeutics position peaked at $124K in Q2 2026.
- 91 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q3 2026.
Based on Wells Fargo's 13F filing for Q3 2026, filed 16 Nov 2026.